Yale in global health consortium

Yale has joined five universities and the Association of University Technology Managers (AUTM) to spur the dissemination of technology and medicines to the developing world.

In a statement released in November, Harvard, Yale, Brown, Boston University, the University of Pennsylvania, Oregon Health & Science University, and AUTM said they will try to ensure that their intellectual property rights do not block access to drugs, vaccines, devices, and medical technologies in developing countries. They also agreed to try to develop licensing strategies that promote global access to health technologies, to control patent rights so as to make lifesaving products available in the developing world, and to support the development of health-related technologies aimed at diseases prevalent in the developing world.

“We believe the principles and strategies enunciated in this document will further our shared goal of providing access to the benefits of our medical inventions for the most needy global citizens,” said Yale President Richard C. Levin.


Other Roundup


Collins named to lead NIH

Francis S. Collins, M.D., Ph.D. ’72, FW ’84, was appointed head of the National Institutes of...

Read more...


New strategy for swine flu

A Yale researcher has proposed a swine flu vaccination strategy that would minimize cases and...

Read more...


How hunger blocks fertility

A molecule that may play a key role in obesity, drug addiction, and depression also turns off the...

Read more...

Download on the Apple App Store